Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
Year : 2021  |  Volume : 19  |  Issue : 2  |  Page : 110-114

Amitriptyline in irritable bowel syndrome: A clinical review

1 Consultant Psychiatrist, Ballarat, Victoria, Australia
2 Monash Health, Monash University, Clayton, Victoria, Australia
3 Monash School of Medicine, Monash University, Clayton, Victoria, Australia

Correspondence Address:
Dr. Mani Rajagopalan
24 Drummond Street North, Ballarat VIC 3350
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/cmi.cmi_13_21

Rights and Permissions

Irritable bowel syndrome is the most common functional gastrointestinal disorder in the primary care setting. Symptoms tend to be long lasting and patients have been reported to have a higher prevalence of psychological distress. Antidepressants have been shown to be effective in its management and we review trials involving amitriptyline. Possible mechanisms of action are discussed.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded339    
    Comments [Add]    

Recommend this journal